Invesco new shareholder in Surgical Science

Invesco’s fund Invesco Global Opportunities has become shareholder in Surgical Science through the acquisition of 800,000 shares. The shares were bought from two board members, Roland Bengtsson and Jan Bengtsson, who through their respective companies sold shares to Invesco.

“We have seen increased interest from North American investors in Surgical Science and are pleased to have Invesco as one of the company's 15 largest owners. It is a long-term owner with a very good reputation and significant financial muscle", says Gisli Hennermark, CEO of Surgical Science.

Frank Jennings is Senior Portfolio Manager for Invesco Global Opportunities, which invests in small and midcap growth companies globally. Frank was a portfolio manager for over 20 years at OppenheimerFunds before they became part of Invesco in 2019. Invesco has total assets of approximately USD 1,500 billion under management.

Gothenburg, Sweden, July 5, 2022
Surgical Science Sweden AB (publ)

The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/aktien/pressmeddelanden/

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is how injuries during care can be reduced. Medical education and training are key, as a large part of the training today can be performed outside the operating room. Surgical Science is a world leader in the manufacture of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psychomotor skills and instrument handling before entering the clinical environment. In parallel with its own products, Surgical Science works with simulation solutions for medical technology companies that develop surgical instruments for clinical use, such as robotic surgery.

Surgical Science has more than 200 employees. The company is headquartered in Gothenburg, Sweden and also has operations in Stockholm, Sweden, as well as in Tel Aviv, Israel and Seattle, US. Through sales offices in the US, France and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Surgical Science Sweden AB (publ) is traded on Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank (Phone: +46 8-463 83 00; E-mail: certifiedadviser@penser.se).

Invesco new shareholder in Surgical Science